The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a press release
to welcome the launch of a new toolkit to ensure female patients are better informed about the risks of taking valproate medicines during pregnancy. This follows on from the strengthened warning on the risk of valproate in pregnancy issued last year by the MHRA.
includes a credit card sized patient card to be issued by pharmacists, booklets for healthcare professionals and for patients together with a checklist of important questions and discussion points to be kept with the patient’s file. Warnings will appear on the medicine’s packaging later this year.
Further information can be found in the MHRA press release
and our Dispensing valproate for girls and women guidance